Maple Capital Management, Inc. Idexx Laboratories Inc Transaction History

Maple Capital Management, Inc.

$1.36 Billion
Q4 2024

A detailed history of Maple Capital Management, Inc. transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Maple Capital Management, Inc. holds 568 shares of IDXX stock, worth $292,139. This represents 0.02% of its overall portfolio holdings.

Number of Shares

568

Previous 568 -0.0%

Holding current value

$292,139

Previous $286,000 18.18%

% of portfolio

0.02%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$468.04 - $548.53 $17,317 - $20,295	-37 Reduced 6.12%	568 $276,000
Q2 2023 Jul 14, 2023	SELL	$450.7 - $503.61 $9,014 - $10,072	-20 Reduced 3.2%	605 $303,000
Q1 2023 May 02, 2023	SELL	$406.01 - $514.59 $3,248 - $4,116	-8 Reduced 1.26%	625 $312,000
Q4 2022 Feb 13, 2023	BUY	$324.64 - $441.27 $1,298 - $1,765	4 Added 0.64%	633 $258,000
Q3 2022 Nov 15, 2022	SELL	$325.8 - $407.78 $4,887 - $6,116	-15 Reduced 2.33%	629 $269,000
Q2 2022 Aug 02, 2022	SELL	$327.37 - $553.44 $5,237 - $8,855	-16 Reduced 2.42%	644 $225,000
Q1 2022 May 17, 2022	SELL	$466.52 - $631.01 $2,332 - $3,155	-5 Reduced 0.75%	660 $361,000
Q2 2021 Aug 16, 2021	SELL	$486.36 - $637.08 $9,727 - $12,741	-20 Reduced 2.92%	665 $447,000
Q4 2020 Feb 12, 2021	SELL	$383.85 - $499.87 $2,303 - $2,999	-6 Reduced 0.87%	685 $342,000
Q2 2020 Aug 12, 2020	BUY	$230.66 - $330.16 $159,386 - $228,140	691 New	691 $228,000
Q3 2019 Nov 14, 2019	SELL	$260.07 - $289.93 $190,891 - $212,808	-734 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$215.53 - $275.33 $158,199 - $202,092	734 New	734 $202,000

Others Institutions Holding IDXX

# of Institutions

1,259

Shares Held

76.3M

Call Options Held

129K

Put Options Held

219K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $42.8B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maple Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maple Capital Management, Inc. with notifications on news.

Account

Maple Capital Management, Inc. Idexx Laboratories Inc Transaction History